Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer

Clinical trial NCT07180082 · RECRUITING

Trial details

NCT number: NCT07180082
Sponsor: Wenjin Yin
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2025-08-28
Primary completion: 2028-09-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.